Delivery Order SPE2DB22D1202-SPE2DB24FUTT7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,483.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $1,388.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 13, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $6,322.56 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of May 21, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,270.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564261561 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there was no set-aside designation used for this award. This delivery order is part of a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,231.06 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medication. The contract has a performance period through June 26, 2025 and is not set aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) the company holds with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, specifically ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has a Firm Fixed Price pricing structure and a total ceiling value of $5,447.12. The period of performance runs through August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support various federal healthcare programs and facilities,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order (SPE2DB22D3004|SPE2DB24FPV63) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product called ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. The order, valued at $1,728.99, has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is a child contract under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,326.19 and a completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $15,271.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of May 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
- This is a $12,262.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products, with a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTT7Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,246.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of pharmaceutical products. Specifically, the contract is for the delivery of the medication "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" with a performance period through March 15, 2024. This order is a part of an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 3/14/24 |